Latest News about Psychedelics Investing
Recent news which mentions Psychedelics Investing
   Psychedelics 2024: Veterans Blessing, Mental Health Paradigm Shift, Providers Training, Ketamine-MDMA Bonds & More
   
  
  
  March 06, 2024
  From Benzinga
 
   Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
   
  
  
  March 04, 2024
  From Benzinga
 
   Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream'
   
  
  
  February 29, 2024
  From Benzinga
 
   Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
   
  
  
  January 15, 2024
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
   
  
  
  December 11, 2023
  From Benzinga
 
   Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More
   
  
  
  October 29, 2023
  From Benzinga
 
   Cybin's FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor
   
  June 28, 2023
  Tickers 
   CYBN
  
  
  From Benzinga
 
   Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More
   
  
  
  June 13, 2023
  From Benzinga
 From Benzinga
 
   Psyched: MDMA Therapy Advances With FDA, Alternatives For Alcohol Addiction, Prince Harry In The Spotlight And More
   
  
  
  April 11, 2023
  From Benzinga
 
   High-Profile Highs: How Celebrity Advocacy Is Transforming Society's Views On Psychedelics And Cannabis
   
  
  
  March 29, 2023
  From Benzinga
 From Benzinga
 
   Psychedelics Producer Lucy Scientific Discovery Partners With Pramantha Group For Funding: What's Next?
   
  March 17, 2023
  Tickers 
   LSDI
  
  
  From Benzinga
 
   Psychedelics Company Conducts Investigation Into Potential Naked Short Selling Of Its Stock
   
  March 14, 2023
  Tickers 
   HUGE
  
  
  From Benzinga
 
   Two Major Psychedelics Companies Take Novel Chemical Entity Patent Battle To Federal Court
   
  
  
  March 14, 2023
  From Benzinga
 
   Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person
   
  
  
  March 08, 2023
  From Benzinga
 From Benzinga
 
   Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
   
  
  
  February 27, 2023
  From Benzinga
 
   [Video] Tech Millionaires Brock Pierce, Jeremy Gardner Venture Into Psychedelics, Seek To Address Mental Health Issues
   
  February 27, 2023
  Tickers 
   TECH
  
  
  From Benzinga
 
   Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
   
  
  
  February 21, 2023
  From Benzinga
 From Benzinga
 
   EXCLUSIVE: Social Equity, Adult-Use, Commercialization & Regs For Psychedelics, Lessons From Cannabis
   
  
  February 08, 2023
  From Benzinga
 
   Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics
   
  
  
  February 06, 2023
  From Benzinga
 
   MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
   
  
  
  February 06, 2023
  From Benzinga
 
   Silo Pharma, Mindset Pharma, Terran Biosciences Receive Psychedelic Treatments Patents, IP Portfolios Expanded
   
  
  
  February 03, 2023
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.